Selective serotonin reuptake inhibitors (SSRIs) and benzodiazepines are commonly used to manage anxiety in Visual Snow Syndrome by modulating neurotransmitter activity, primarily targeting serotonergic and GABAergic pathways. These medications aim to reduce neural hyperexcitability and provide symptomatic relief by decreasing cortical hyperactivity and mitigating sensory processing abnormalities associated with the syndrome.